Peer-influenced content. Sources you trust. No registration required. This is HCN.

Medical News Today (MNT)AI Finds Several Early Risk Factors to Predict Alzheimer’s 7 Years Early

AI-Driven Insights Unveil Early Risk Factors and Gender-Specific Links in Alzheimer’s Prediction

In a recent study by the University of California San Francisco, artificial intelligence (AI) has been employed to unearth early risk factors for Alzheimer’s disease, potentially changing early detection and preventive strategies. This research not only emphasizes known risk factors but also highlights gender-specific indicators, offering a nuanced approach to understanding and combating this neurodegenerative condition.

Key Points:

  • Researchers utilized AI to analyze clinical data from more than 5 million individuals, identifying early risk factors for Alzheimer’s disease.
  • The study achieved a prediction accuracy of 72% for Alzheimer’s onset up to seven years prior to symptom manifestation.
  • Identified risk factors include high blood pressure, high cholesterol, and vitamin D deficiency, prevalent in both men and women.
  • Gender-specific risk factors were also identified: erectile dysfunction and an enlarged prostate in men, and osteoporosis in women.
  • The research underscores the importance of early detection in Alzheimer’s, allowing for potential intervention before significant cognitive decline.
  • AI’s role in the study emphasizes its capability to handle vast datasets and identify patterns that may not be immediately evident to human analysts.
  • The findings suggest a connection between systemic health issues and Alzheimer’s risk, advocating for a holistic approach to prevention.
  • This study supports the notion that managing cardiovascular and bone health could be integral to Alzheimer’s prevention, especially in women.

“We use AI to be able to account for this complexity, and we choose to pursue interpretability so that our model is not a ‘black box’ AI model, but one that can tell us what these early risk factors are in the AI decision-making so a clinician looking at the results can also choose to believe in the AI or not depending on those factors.”
– Alice S. Tang, lead author

More on Alzheimer’s Disease/Dementia

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form